Dr. Johnson on Promise of Combination Therapy in Melanoma
4 意见
• 07/30/23
0
0
嵌入
Douglas B. Johnson, MD, assistant professor of medicine, Vanderbilt University Medical Center, clinical director, Melanoma Research Program, Vanderbilt-Ingram Cancer Center, discusses the promise of combination therapy in patients with melanoma.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论